Home1513 • HKG
Follow
Livzon Pharmaceutical Group Inc
Previous close
$25.50
Day range
$25.40 - $26.50
Year range
$21.50 - $30.15
Market cap
33.57B HKD
Avg Volume
635.14K
P/E ratio
11.26
Dividend yield
-
Market news
Financials
Income Statement
Revenue
Net income
| (CNY) | Dec 2023info | Y/Y change |
|---|---|---|
Revenue | 2.78B | -11.65% |
Operating expense | 1.43B | -14.68% |
Net income | 352.10M | -12.55% |
Net profit margin | 12.69 | -1.01% |
Earnings per share | — | — |
EBITDA | 253.89M | -18.99% |
Effective tax rate | 33.76% | — |
Balance Sheet
Total assets
Total liabilities
| (CNY) | Dec 2023info | Y/Y change |
|---|---|---|
Cash and short-term investments | 11.41B | 8.44% |
Total assets | 25.04B | 0.71% |
Total liabilities | 10.28B | 3.49% |
Total equity | 14.77B | — |
Shares outstanding | 923.94M | — |
Price to book | 1.68 | — |
Return on assets | 0.51% | — |
Return on capital | 0.68% | — |
Cash Flow
Net change in cash
| (CNY) | Dec 2023info | Y/Y change |
|---|---|---|
Net income | 352.10M | -12.55% |
Cash from operations | 1.04B | 12.09% |
Cash from investing | -154.44M | 66.48% |
Cash from financing | 111.42M | 199.25% |
Net change in cash | 980.52M | 98.40% |
Free cash flow | 1.25B | 53.37% |
About
Founded
Jan 26, 1985
Website
Employees
8,933
